Literature DB >> 11461113

Importance of poly(ADP-ribose) glycohydrolase in the control of poly(ADP-ribose) metabolism.

L Davidovic1, M Vodenicharov, E B Affar, G G Poirier.   

Abstract

Poly(ADP-ribosyl)ation is a posttranslational modification that alters the functions of the acceptor proteins and is catalyzed by the poly(ADP-ribose) polymerase (PARP) family of enzymes. Following DNA damage, activated poly(ADP-ribose) polymerase-1 (PARP-1) catalyzes the elongation and branching of poly(ADP-ribose) (pADPr) covalently attached to nuclear target proteins. Although the biological role of poly(ADP-ribosyl)ation has not yet been defined, it has been implicated in many important cellular processes such as DNA repair and replication, modulation of chromatin structure, and apoptosis. The transient nature and modulation of poly(ADP-ribosyl)ation depend on the activity of a unique cytoplasmic enzyme called poly(ADP-ribose) glycohydrolase which hydrolyzes pADPr bound to acceptor proteins in free ADP-ribose residues. While the PARP homologues have been recently reviewed, there are relatively scarce data about PARG in the literature. Here we summarize the latest advances in the PARG field, addressing the question of its putative nucleo-cytoplasmic shuttling that could enable the tight regulation of pADPr metabolism. This would contribute to the elucidation of the biological significance of poly(ADP-ribosyl)ation. Copyright 2001 Academic Press.

Entities:  

Mesh:

Substances:

Year:  2001        PMID: 11461113     DOI: 10.1006/excr.2001.5263

Source DB:  PubMed          Journal:  Exp Cell Res        ISSN: 0014-4827            Impact factor:   3.905


  99 in total

1.  TRF1 is degraded by ubiquitin-mediated proteolysis after release from telomeres.

Authors:  William Chang; Jasmin N Dynek; Susan Smith
Journal:  Genes Dev       Date:  2003-06-01       Impact factor: 11.361

2.  Loss of poly(ADP-ribose) glycohydrolase causes progressive neurodegeneration in Drosophila melanogaster.

Authors:  Shuji Hanai; Masayuki Kanai; Sayaka Ohashi; Keiji Okamoto; Mitsunori Yamada; Hitoshi Takahashi; Masanao Miwa
Journal:  Proc Natl Acad Sci U S A       Date:  2003-12-15       Impact factor: 11.205

Review 3.  Parthanatos: mitochondrial-linked mechanisms and therapeutic opportunities.

Authors:  Amos A Fatokun; Valina L Dawson; Ted M Dawson
Journal:  Br J Pharmacol       Date:  2014-04       Impact factor: 8.739

4.  Poly(ADP-ribose) glycohydrolase is a component of the FMRP-associated messenger ribonucleoparticles.

Authors:  Jean-Philippe Gagné; Marie-Eve Bonicalzi; Pierre Gagné; Marie-Eve Ouellet; Michael J Hendzel; Guy G Poirier
Journal:  Biochem J       Date:  2005-12-15       Impact factor: 3.857

Review 5.  Function and pharmacology of TRPM cation channels.

Authors:  Christian Harteneck
Journal:  Naunyn Schmiedebergs Arch Pharmacol       Date:  2005-04       Impact factor: 3.000

6.  The macro domain is an ADP-ribose binding module.

Authors:  Georgios I Karras; Georg Kustatscher; Heeran R Buhecha; Mark D Allen; Céline Pugieux; Fiona Sait; Mark Bycroft; Andreas G Ladurner
Journal:  EMBO J       Date:  2005-05-19       Impact factor: 11.598

Review 7.  The role of TRP channels in oxidative stress-induced cell death.

Authors:  B A Miller
Journal:  J Membr Biol       Date:  2006-04-17       Impact factor: 1.843

Review 8.  Mitochondrial dysfunction and NAD(+) metabolism alterations in the pathophysiology of acute brain injury.

Authors:  Katrina Owens; Ji H Park; Rosemary Schuh; Tibor Kristian
Journal:  Transl Stroke Res       Date:  2013-08-10       Impact factor: 6.829

Review 9.  Mitochondrial and nuclear cross talk in cell death: parthanatos.

Authors:  Shaida A Andrabi; Ted M Dawson; Valina L Dawson
Journal:  Ann N Y Acad Sci       Date:  2008-12       Impact factor: 5.691

10.  Structure of human ADP-ribosyl-acceptor hydrolase 3 bound to ADP-ribose reveals a conformational switch that enables specific substrate recognition.

Authors:  Yasin Pourfarjam; Jessica Ventura; Igor Kurinov; Ahra Cho; Joel Moss; In-Kwon Kim
Journal:  J Biol Chem       Date:  2018-06-15       Impact factor: 5.157

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.